IMF Videos Search Content For Care Partner (351) Patient (347) Healthcare Provider (213) Healthcare Professional (210) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (22) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (21) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (185) Financial Considerations (15) Frontline Therapy (83) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (69) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (56) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (42) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (136) Research Updates (193) Symptom Management (114) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (147) High-Risk Myeloma (96) High-risk Smoldering Myeloma (70) Late Relapse (4–6 Lines of Therapy) (158) MGUS (85) Newly Diagnosed (Pre-Treatment or First Treatment) (158) Smoldering Myeloma (109) Types of Therapy Immunomodulatory drugs (IMiDs) (94) Immunotherapies (CAR T; BiTE, etc.) (161) Monoclonal antibodies (78) Proteasome inhibitors (66) Stem cell transplant (84) Steroids (63) Supportive Care (152) Year Published 2026 (44) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (103) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (29) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Cultivating the Future of Myeloma Care July 18, 2023 Health Equity Myeloma University | Monoclonal Antibodies as Treatment for Multiple Myeloma July 18, 2023 Myeloma University Myeloma University | The Patient Journey and CAR-T Therapy Management in Multiple Myeloma July 18, 2023 Myeloma University Myeloma University | Learn About Renal (Kidney) Impairment in Patients with Multiple Myeloma July 18, 2023 Myeloma University Phase 3, open-label, randomized trial comparing safety and efficacy of belamaf to Pd in RRMM: DREAMM-3 study July 10, 2023 ASCO/EHA CARTITUDE-1: Final results of Ciltacabtagene Autoleucel in heavily pretreated relapsed/refractory multiple myeloma July 7, 2023 ASCO/EHA Pivotal phase 2 MonumenTAL-1 results of talquetamab, a GPRC5DxCD3 bispecific antibody, for relapsed refractory multiple myeloma July 3, 2023 ASCO/EHA Quadruplet Induction Therapy, ASCT and MRD-modulated Consolidation and Treatment Cessation in Newly Diagnosed Multiple Myeloma July 1, 2023 ASCO/EHA Maintenance Therapy with Carfilzomib, Pomalidomide, and Dex (KPd) in High-Risk Myeloma Patients June 30, 2023 ASCO/EHA Updated Results of BCMA/CD19 Dual-targeting Fast CAR-T GC012F Dual-targeting CAR-T in RRMM June 30, 2023 ASCO/EHA Safety and Efficacy of elranatamab in RRMM & Prior BCMA Therapies: Analysis from MagnetisMM Studies June 29, 2023 ASCO/EHA Myeloma Made Simple: Care Partners (Caregivers) Made Simple | What Is a Care Partner? June 29, 2023 Myeloma Made Simple Load More
